DSE : ACMELAB

The ACME Laboratories Ltd.

Pharmaceutical Preparations · Bangladesh

Last price 77.9 BDT (At close: Oct 29, 2026) · Market cap 16.48B

Latest research: The ACME Laboratories valuation report: fair value BDT 64.9–137 (Oct 2026) · ACME's debt took 48% of FY2025 operating profit, limiting fair value to BDT 65–137 (base 105)

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacturing, marketing, and distribution of generic pharmaceutical formulation products in Bangladesh. The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and ...

Technical report: trend, RSI, support and resistance, charts

Reports